MC809A1 - Nouveaux dialkylaminoalkylethers du 2-alcoxy-3,5-dihalogenobenzene et leur procédé de préparation - Google Patents

Nouveaux dialkylaminoalkylethers du 2-alcoxy-3,5-dihalogenobenzene et leur procédé de préparation

Info

Publication number
MC809A1
MC809A1 MC808A MC808A MC809A1 MC 809 A1 MC809 A1 MC 809A1 MC 808 A MC808 A MC 808A MC 808 A MC808 A MC 808A MC 809 A1 MC809 A1 MC 809A1
Authority
MC
Monaco
Prior art keywords
dichlorobenzene
methoxy
hydrochloride
preparing
ethoxy
Prior art date
Application number
MC808A
Other languages
English (en)
French (fr)
Original Assignee
Soc Et Scient Et Ind De L Ile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR151632A external-priority patent/FR7615M/fr
Application filed by Soc Et Scient Et Ind De L Ile filed Critical Soc Et Scient Et Ind De L Ile
Publication of MC809A1 publication Critical patent/MC809A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Insulating Bodies (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC808A 1968-02-16 1969-02-13 Nouveaux dialkylaminoalkylethers du 2-alcoxy-3,5-dihalogenobenzene et leur procédé de préparation MC809A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR140294 1968-02-16
FR151632A FR7615M (OSRAM) 1968-05-10 1968-05-10

Publications (1)

Publication Number Publication Date
MC809A1 true MC809A1 (fr) 1970-07-30

Family

ID=26181810

Family Applications (1)

Application Number Title Priority Date Filing Date
MC808A MC809A1 (fr) 1968-02-16 1969-02-13 Nouveaux dialkylaminoalkylethers du 2-alcoxy-3,5-dihalogenobenzene et leur procédé de préparation

Country Status (21)

Country Link
JP (1) JPS4934669B1 (OSRAM)
BE (1) BE728221A (OSRAM)
BG (1) BG15205A3 (OSRAM)
BR (1) BR6906462D0 (OSRAM)
CA (1) CA928299A (OSRAM)
CH (1) CH490328A (OSRAM)
CS (1) CS155198B2 (OSRAM)
DK (1) DK125020B (OSRAM)
ES (1) ES363662A1 (OSRAM)
FI (1) FI50789C (OSRAM)
GB (1) GB1251695A (OSRAM)
IE (1) IE32961B1 (OSRAM)
IL (1) IL31594A (OSRAM)
LU (1) LU58009A1 (OSRAM)
MC (1) MC809A1 (OSRAM)
NL (1) NL138921B (OSRAM)
NO (1) NO128958B (OSRAM)
OA (1) OA03885A (OSRAM)
SE (1) SE367184B (OSRAM)
YU (1) YU33793B (OSRAM)
ZM (1) ZM969A1 (OSRAM)

Also Published As

Publication number Publication date
DE1906551B2 (de) 1975-07-17
NL138921B (nl) 1973-05-15
NL6902401A (OSRAM) 1969-08-19
IE32961L (en) 1969-08-16
OA03885A (fr) 1975-08-14
FI50789C (fi) 1976-07-12
BG15205A3 (bg) 1972-05-20
LU58009A1 (OSRAM) 1969-09-18
JPS4934669B1 (OSRAM) 1974-09-17
IL31594A0 (en) 1969-04-30
SE367184B (OSRAM) 1974-05-20
YU33793B (en) 1978-05-15
ZM969A1 (en) 1969-11-17
IL31594A (en) 1973-02-28
BR6906462D0 (pt) 1973-01-16
ES363662A1 (es) 1971-01-01
DE1906551A1 (de) 1969-08-21
YU33269A (en) 1977-10-31
CA928299A (en) 1973-06-12
CS155198B2 (OSRAM) 1974-05-30
DK125020B (da) 1972-12-18
CH490328A (fr) 1970-05-15
FI50789B (OSRAM) 1976-03-31
GB1251695A (OSRAM) 1971-10-27
IE32961B1 (en) 1974-02-06
NO128958B (OSRAM) 1974-02-04
BE728221A (OSRAM) 1969-08-11

Similar Documents

Publication Publication Date Title
CA1196650A (fr) Derives d'aminoethoxy-4 isopropyl-5 methyl-2 phenyl leur methode de preparation et leur emploi en tant que medicaments
EP0021940B1 (fr) Nouveaux dérivés aminés du benzothiazole, leur procédé de préparation et leur application en thérapeutique
FR2584713A1 (fr) Nouveaux derives de l'indole carboxamide, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
CH619935A5 (OSRAM)
WO1990003972A1 (fr) Derives de methyl-4 ((phenyl-4 piperazinyl-1)-2 ethyl)-5 thiazole
FR2503705A1 (fr) Derives de phenethanolamine, leur preparation et leur application en therapeutique
CH637112A5 (fr) Derives benzylideniques.
CH637650A5 (fr) Procede de preparation d'un acide chromone carboxylique.
CA1060020A (fr) Procede de preparation de nouveaux derives de la dibenzo/b,c/ thiepine et leurs sels
EP0082040B1 (fr) Dérivés de diaza-3,7a cyclohepta(j,k)fluorènes, leur préparation et leur application en thérapeutique
EP0151052B1 (fr) Aminoéthylimidazole, composition pharmaceutique en contenant et procédé de préparation
FR2584401A1 (fr) Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
MC806A1 (fr) Procédé de préparation de benzamides hétérocycliques nouveaux
EP0288647B1 (fr) Dérivés du [(pyrrolidinyl-1)-2éthoxy]-5 p-cymène, le procédé de préparation desdits dérivés et les médicaments contenant lesdits dérivés
EP0015817A1 (fr) Nouveaux dérivés de la pipéridine, leur procédé de préparation et leur application en thérapeutique
FR2708611A1 (fr) Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant.
EP0057141B1 (fr) Esters d'halogéno biphénylcarboxylates, leur procédé de préparation et leur application en tant que médicaments
FR2581643A1 (fr) Compositions pharmaceutiques utiles dans le domaine de l'urologie, contenant de l'acetoxy-1 methyl-2 ((piperidino)-2 ethoxy)-4 (methyl-1 ethyl)-5 benzene ou l'un de ses sels
FR2583047A1 (fr) Procede de preparation de derives du 4-phenylpropyl indole, et intermediaires
FR2593501A1 (fr) Nouveaux derives bis (r-oxyimino)-5,7 dihydro-6,7 (5h) dibenzo (a,c) cycloheptene, leurs procedes de preparation et leur application comme medicaments
CH637378A5 (fr) Benzamides cycloalkylalkyliques.
FR2523577A1 (fr) Derives de l'acide d-2-(6-methoxy-2-naphtyl)-propionique doues d'activite therapeutique, leur procede de preparation et compositions pharmaceutiques qui en renferment
FR2763589A1 (fr) Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention
EP0275221A2 (fr) Nouveaux dérivés du N-(1H-indol 4-yl) benzamide ainsi que leurs sels, leur application à titre de médicaments et les compositions les renfermant
EP0237411A1 (fr) (Pipéridino-3)propoxy - 5p.cymène, les dérivés acétyl, acétoxy et hydroxy dudit produit, les sels de ces produits un procédé de préparation desdits produits et les médicaments contenant au moins un de ces produits comme principe actif